SK

Sebastian Kreuz

Executive Director / Investment Manager at Boehringer Ingelheim Venture Fund

Ingelheim am Rhein, Rhineland-Palatinate

Investor
VC

Invests in

Stages:

Seed
Series A

Locations:

Germany

  • Min Investment:

    $3,250,000.00

  • Max Investment:

    $17,000,000.00

  • Target Investment:

    $8,500,000.00

Skills

Drug discovery
Respiratory Diseases (Lung Fibrosis, COPD, Cystic Fibrosis)
Novel therapeutic modalities (Gene Therapy, siRNAs, Aptamers)
Pharmaceutical Industry
Biotechnology
Start-ups
Infectious Diseases
Immuno Oncology
Synthetic Biology
Life Sciences
Gene Therapy

Investments

smartbax

Seed

Total Funding: $1M

Centauri Therapeutics

Series A

Total Funding: $33M

Work Experience

Boehringer Ingelheim

2004

  • Executive Director / Investment Manager (BI Venture Fund)

    2019

    Boehringer Ingelheim Venture Fund (BIVF) at Boehringer Ingelheim

  • Associate Director (Research Beyond Borders)

    2015 - 2019

    Gene Therapy Group (Research Beyond Borders) at Boehringer Ingelheim

  • Project Leader (Immunology & Respiratory Diseases Research)

    2013 - 2015

    Immunology & Respiratory Diseases Research (I&R) at Boehringer Ingelheim

  • Laboratory Head (Target Discovery Research)

    2006 - 2012

    Target Discovery Research (TDR) at Boehringer Ingelheim

  • Postdoctoral Researcher (Functional Genomics)

    2004 - 2005

    Global Skill Center Functional Genomics at Boehringer Ingelheim